{"id":"https://openalex.org/W2010194027","doi":"https://doi.org/10.1158/1538-7445.am2012-2877","title":"Abstract 2877: Perifosine alone and in combination with antimetabolites interferes with NF-kB pathway activation in colon cancer cell lines","display_name":"Abstract 2877: Perifosine alone and in combination with antimetabolites interferes with NF-kB pathway activation in colon cancer cell lines","publication_year":2012,"publication_date":"2012-04-01","ids":{"openalex":"https://openalex.org/W2010194027","doi":"https://doi.org/10.1158/1538-7445.am2012-2877","mag":"2010194027"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2012-2877","doi":"https://doi.org/10.1158/1538-7445.am2012-2877","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-2877","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026087941","display_name":"Babette Aicher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142512","display_name":"Aeterna Zentaris (Germany)","ror":"https://ror.org/03v0txq34","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210142512"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Babette Aicher","raw_affiliation_strings":["1Aeterna Zentaris GmbH, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Aeterna Zentaris GmbH, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210142512"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091020854","display_name":"Peter M. Schmidt","orcid":"https://orcid.org/0000-0003-1340-9086","observed_orcids":["https://orcid.org/0000-0003-1340-9086"]},"institutions":[{"id":"https://openalex.org/I4210142512","display_name":"Aeterna Zentaris (Germany)","ror":"https://ror.org/03v0txq34","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210142512"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Peter Schmidt","raw_affiliation_strings":["1Aeterna Zentaris GmbH, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Aeterna Zentaris GmbH, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210142512"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108514988","display_name":"J\u00fcrgen Engel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142512","display_name":"Aeterna Zentaris (Germany)","ror":"https://ror.org/03v0txq34","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210142512"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ju\u0308rgen Engel","raw_affiliation_strings":["1Aeterna Zentaris GmbH, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Aeterna Zentaris GmbH, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210142512"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065186410","display_name":"Eckhard Guenther","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142512","display_name":"Aeterna Zentaris (Germany)","ror":"https://ror.org/03v0txq34","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210142512"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Eckhard G. Guenther","raw_affiliation_strings":["1Aeterna Zentaris GmbH, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Aeterna Zentaris GmbH, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210142512"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074434713","display_name":"Michael Teifel","orcid":"https://orcid.org/0009-0006-6635-8517","observed_orcids":["https://orcid.org/0009-0006-6635-8517"]},"institutions":[{"id":"https://openalex.org/I4210142512","display_name":"Aeterna Zentaris (Germany)","ror":"https://ror.org/03v0txq34","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210142512"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Michael Teifel","raw_affiliation_strings":["1Aeterna Zentaris GmbH, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Aeterna Zentaris GmbH, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210142512"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210142512"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"72","issue":"8_Supplement","first_page":"2877","last_page":"2877"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11591","display_name":"NF-\u03baB Signaling Pathways","score":0.8827999830245972,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11591","display_name":"NF-\u03baB Signaling Pathways","score":0.8827999830245972,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.06830000132322311,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12620","display_name":"Signaling Pathways in Disease","score":0.014800000004470348,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/perifosine","display_name":"perifosine","score":0.9769999980926514},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.8220000267028809},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.875},{"id":"https://openalex.org/keywords/antimetabolites","display_name":"antimetabolites","score":0.9139999747276306},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/akt-inhibitors","display_name":"AKT inhibitors","score":0.5580000281333923},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.5839999914169312},{"id":"https://openalex.org/keywords/antimetabolite-resistance","display_name":"antimetabolite resistance","score":0.8600000143051147},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.7310000061988831},{"id":"https://openalex.org/keywords/sw620-cells","display_name":"SW620 cells","score":0.8109999895095825},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.503000020980835},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.7310000061988831},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5070000290870667},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.5130000114440918},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":0.45899999141693115}],"concepts":[{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5750592947006226},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5449804067611694},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5078833699226379},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.5077744126319885},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.499340295791626},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4878659248352051},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4753429889678955},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.46708130836486816},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.44031015038490295},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4340231716632843},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.41033026576042175},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3204716742038727},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30677223205566406},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.27927398681640625},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1831899881362915},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.16780701279640198},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15524950623512268},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13226008415222168},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.10759058594703674},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06132933497428894}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2012-2877","doi":"https://doi.org/10.1158/1538-7445.am2012-2877","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-2877","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2153259757","https://openalex.org/W3010448894","https://openalex.org/W2142687511","https://openalex.org/W2006099659","https://openalex.org/W2014961333","https://openalex.org/W4311604435","https://openalex.org/W2157252371","https://openalex.org/W2155691517","https://openalex.org/W2041903098","https://openalex.org/W2153653048"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Perifosine,":[2],"a":[3,133,142],"novel,":[4],"first-in-class,":[5],"oral":[6],"Akt":[7],"inhibitor,":[8],"in":[9,17,36,45,59,93,102,189,192,229,288,298,302,316,327],"combination":[10,37,299,317],"with":[11,38,66,91,197,271,278,300,318],"the":[12,23,77,88,108,211,223,230,235,257,263,274,279,371,376],"antimetabolite":[13,282],"Capecitabine":[14],"is":[15,56,64],"currently":[16],"Phase":[18],"III":[19],"clinical":[20],"trials":[21],"for":[22,126,379],"treatment":[24],"of":[25,76,84,118,129,171,200,219,222,237,256,265,267,281,296,370,375],"refractory":[26],"advanced":[27],"colorectal":[28,60],"cancer.":[29,290],"We":[30],"have":[31],"shown":[32],"previously":[33],"that":[34,254],"Perifosine":[35,82,183,240,272,315],"antimetabolites":[39,92,224,239,301,319],"displayed":[40],"synergistic":[41,321],"cytotoxicity":[42,154,324],"and":[43,48,86,155,325,334,346],"apoptosis":[44,156,326],"colon":[46,94,136,289],"cancer":[47,61,95,137,304],"other":[49],"cell":[50,96,138,305,337],"lines":[51,306],"[1].":[52],"Constitutive":[53],"NF-kB":[54,78,100,110,119,130,143,187,227,246,258,286],"activation":[55,101,188,287],"frequently":[57],"observed":[58,89],"and,":[62],"moreover,":[63],"associated":[65],"resistance":[67,283],"to":[68,81,87,120,166,207,244,262,276,285],"chemotherapy":[69],"[2].":[70],"Hence":[71],"we":[72],"analysed,":[73],"wether":[74],"downregulation":[75,255],"pathway":[79,131,259],"contributes":[80],"mechanism":[83,264,295],"action":[85,266,297],"synergism":[90],"lines.":[97,338],"Methods:":[98],"Cellular":[99,153],"nuclear":[103],"extracts":[104],"was":[105,151,174,241],"measured":[106],"by":[107,176,216],"TransAm":[109],"p65":[111],"ELISA":[112],"(Active":[113],"Motif,":[114],"USA)":[115,150],"monitoring":[116],"binding":[117],"its":[121],"response":[122,144],"element.":[123],"To":[124],"allow":[125],"higher":[127],"throughput":[128],"analysis":[132,170],"monoclonal":[134],"SW620":[135,190],"line":[139],"ectopically":[140],"expressing":[141],"element":[145],"driven":[146],"reporter":[147,231],"gene":[148,232],"(Promega,":[149],"established.":[152],"assays":[157],"as":[158,160],"well":[159],"western":[161],"blotting":[162],"were":[163,213],"performed":[164],"according":[165],"standard":[167],"procedures.":[168],"The":[169],"drug":[172],"combinations":[173],"conducted":[175],"CalcuSyn":[177],"software":[178],"(Biosoft,":[179],"UK)":[180],"[3].":[181],"Results:":[182],"pretreatment":[184],"decreased":[185],"TNF\u03b1-induced":[186],"cells":[191],"both":[193],"independent":[194],"assay":[195],"sytems":[196],"IC50":[198],"values":[199],"about":[201],"7-10":[202],"\u00b5M.":[203],"This":[204],"effect":[205],"seems":[206],"be":[208],"specific,":[209],"since":[210],"results":[212,252],"not":[214],"mimicked":[215],"cytotoxic":[217],"effects":[218,322],"Perifosine.":[220,268],"Some":[221],"alone":[225],"upregulated":[226],"activity":[228],"assay.":[233],"In":[234,249],"presence":[236],"these":[238,251],"still":[242],"capable":[243],"downregulate":[245],"activity.":[247],"Conclusions:":[248],"summary,":[250],"demonstrate":[253],"may":[260],"contribute":[261],"Moreover,":[269],"cotreatment":[270],"has":[273],"potential":[275],"interfere":[277],"development":[280],"due":[284],"Further":[291],"experiments":[292],"addressing":[293],"Perifosine's":[294],"gastric":[303],"are":[307],"ongoing.":[308],"References":[309],"[1]":[310],"Aicher":[311],"et":[312],"al.":[313],"(2010),":[314,348],"induces":[320],"on":[323],"human":[328],"colon,":[329],"multiple":[330],"myeloma,":[331],"breast,":[332],"renal,":[333],"liver":[335],"tumor":[336],"AACR-NCI-EORTC":[339],"International":[340],"Conference,":[341],"Berlin,":[342],"Germany.":[343],"[2]":[344],"Sakamoto":[345],"Maeda":[347],"Expert.":[349],"Opin.":[350],"Ther.":[351],"Targets":[352],"14,":[353],"593-601":[354],"[3]":[355],"Chou":[356],"(2006),":[357],"Pharmacological":[358],"Reviews":[359],"58,":[360],"621-681":[361],"Citation":[362],"Format:":[363],"{Authors}.":[364],"{Abstract":[365],"title}":[366],"[abstract].":[367],"In:":[368],"Proceedings":[369],"103rd":[372],"Annual":[373],"Meeting":[374],"American":[377],"Association":[378],"Cancer":[380,391],"Research;":[381],"2012":[382],"Mar":[383],"31-Apr":[384],"4;":[385],"Chicago,":[386],"IL.":[387],"Philadelphia":[388],"(PA):":[389],"AACR;":[390],"Res":[392],"2012;72(8":[393],"Suppl):Abstract":[394],"nr":[395],"2877.":[396],"doi:1538-7445.AM2012-2877":[397]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}